drugset / Trial / NCT06309355
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is to evaluate the safety, tolerability, and pharmacokinetics of YR001 topical ointment in adult patients with mild to moderate atopic dermatitis
Timeline
- Start
- 2024-06-19
- Primary completion
- 2025-11-20
- Completion
- 2025-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YR001 | Unknown | — | Topical |